Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1988 3
1989 7
1990 7
1991 4
1992 1
1993 3
1994 4
1995 5
1996 7
1997 4
1998 2
1999 5
2000 2
2001 5
2002 4
2003 1
2004 3
2005 1
2006 4
2007 8
2008 6
2009 13
2010 5
2011 2
2012 2
2013 4
2014 2
2015 2
2016 1
2018 1
2022 0
Text availability
Article attribute
Article type
Publication date

Search Results

105 results
Results by year
Filters applied: . Clear all
Page 1
Transcriptome classification of HCC is related to gene alterations and to new therapeutic targets.
Boyault S, Rickman DS, de Reyniès A, Balabaud C, Rebouissou S, Jeannot E, Hérault A, Saric J, Belghiti J, Franco D, Bioulac-Sage P, Laurent-Puig P, Zucman-Rossi J. Boyault S, et al. Among authors: franco d. Hepatology. 2007 Jan;45(1):42-52. doi: 10.1002/hep.21467. Hepatology. 2007. PMID: 17187432
G1 tumors were associated with low copy number of HBV and overexpression of genes expressed in fetal liver and controlled by parental imprinting. G2 included HCCs infected with a high copy number of HBV and mutations in PIK3CA and TP53. ...
G1 tumors were associated with low copy number of HBV and overexpression of genes expressed in fetal liver and controlled by parental …
Hepatocyte transplantation in animal models.
Weber A, Groyer-Picard MT, Franco D, Dagher I. Weber A, et al. Among authors: franco d. Liver Transpl. 2009 Jan;15(1):7-14. doi: 10.1002/lt.21670. Liver Transpl. 2009. PMID: 19109838 Free article. Review.
Although other cell sources, particularly hepatic and extrahepatic stem cells, are being explored, adult hepatocytes remain the cells of choice for the treatment of liver diseases by cell therapy. In recent years, diverse approaches have been developed in various animal mo …
Although other cell sources, particularly hepatic and extrahepatic stem cells, are being explored, adult hepatocytes remain the cells of cho …
Towards a bioengineered liver.
Franco D. Franco D. J Hepatol. 2014 Feb;60(2):455-6. doi: 10.1016/j.jhep.2013.09.014. Epub 2013 Sep 20. J Hepatol. 2014. PMID: 24060856 Free article. No abstract available.
Role of surgical therapy in management of intractable ascites.
Elcheroth J, Vons C, Franco D. Elcheroth J, et al. Among authors: franco d. World J Surg. 1994 Mar-Apr;18(2):240-5. doi: 10.1007/BF00294408. World J Surg. 1994. PMID: 8042329 Review.
When large-volume paracentesis fails to relieve ascites, patients may be submitted to one of the three following surgical options: portosystemic shunting, peritoneovenous shunting, or liver transplantation. Portosystemic shunting is efficient in clearing ascites, but it is …
When large-volume paracentesis fails to relieve ascites, patients may be submitted to one of the three following surgical options: portosyst …
Liver resection and needle liver biopsy cause hematogenous dissemination of liver cells.
Louha M, Nicolet J, Zylberberg H, Sabile A, Vons C, Vona G, Poussin K, Tournebize M, Capron F, Pol S, Franco D, Lacour B, Bréchot C, Paterlini-Bréchot P. Louha M, et al. Among authors: franco d. Hepatology. 1999 Mar;29(3):879-82. doi: 10.1002/hep.510290348. Hepatology. 1999. PMID: 10051492
We have investigated whether liver resection and needle liver biopsy cause dissemination of liver cells into peripheral blood circulation, using a reverse-transcription polymerase chain reaction (RT-PCR)-based assay targeted against alpha-fetoprotein (AFP) mR …
We have investigated whether liver resection and needle liver biopsy cause dissemination of liver cells into peripheral …
[Symptomatic hepatic angiomyolipoma].
Carloni A, Tranchart H, Beauthier V, Mas AE, Dagher I, Dumas De La Roque A, Landau A, Franco D. Carloni A, et al. Among authors: franco d. Gastroenterol Clin Biol. 2007 May;31(5):555-6. doi: 10.1016/s0399-8320(07)89428-0. Gastroenterol Clin Biol. 2007. PMID: 17541350 Free article. French. No abstract available.
Systemic AA Amyloidosis Caused by Inflammatory Hepatocellular Adenoma.
Calderaro J, Letouzé E, Bayard Q, Boulai A, Renault V, Deleuze JF, Bestard O, Franco D, Zafrani ES, Nault JC, Moutschen M, Zucman-Rossi J. Calderaro J, et al. Among authors: franco d. N Engl J Med. 2018 Sep 20;379(12):1178-1180. doi: 10.1056/NEJMc1805673. N Engl J Med. 2018. PMID: 30231230 Free article. No abstract available.
Laparoscopic liver resection: results for 70 patients.
Dagher I, Proske JM, Carloni A, Richa H, Tranchart H, Franco D. Dagher I, et al. Among authors: franco d. Surg Endosc. 2007 Apr;21(4):619-24. doi: 10.1007/s00464-006-9137-0. Epub 2007 Feb 8. Surg Endosc. 2007. PMID: 17285378
The authors report their experience with laparoscopic liver resection, the evolution of the technique, and the results. METHODS: From 1999 to 2006, 70 laparoscopic liver resections were performed using a procedure similar to resection by laparotomy. ...
The authors report their experience with laparoscopic liver resection, the evolution of the technique, and the results. METHODS: From …
Laparoscopic hepatectomy for hepatocellular carcinoma: a European experience.
Dagher I, Belli G, Fantini C, Laurent A, Tayar C, Lainas P, Tranchart H, Franco D, Cherqui D. Dagher I, et al. Among authors: franco d. J Am Coll Surg. 2010 Jul;211(1):16-23. doi: 10.1016/j.jamcollsurg.2010.03.012. Epub 2010 May 26. J Am Coll Surg. 2010. PMID: 20610244
Between 1998 and 2008, 163 liver resections for hepatocellular carcinoma were performed. Liver parenchyma was cirrhotic in 120 (73.6%) patients. Liver resection was anatomic in 107 (65.6%) patients and was a major resection (>or=3 segments) in 16 (9.8%). . …
Between 1998 and 2008, 163 liver resections for hepatocellular carcinoma were performed. Liver parenchyma was cirrhotic in 120 …
Ex vivo liver-directed gene therapy for the treatment of metabolic diseases: advances in hepatocyte transplantation and retroviral vectors.
Nguyen TH, Mainot S, Lainas P, Groyer-Picard MT, Franco D, Dagher I, Weber A. Nguyen TH, et al. Among authors: franco d. Curr Gene Ther. 2009 Apr;9(2):136-49. doi: 10.2174/156652309787909481. Curr Gene Ther. 2009. PMID: 19355871 Review.
Transplantation of hepatocytes, whether genetically modified or not, has become an alternative to orthotopic liver transplantation for the treatment of patients with metabolic disease. ...Given the shortage of organs and problems related to immunosuppression on one hand, a …
Transplantation of hepatocytes, whether genetically modified or not, has become an alternative to orthotopic liver transplantation fo …
105 results